Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis Low-Income Assistance Will Extend From Medicare Discount Card To Part D Benefit

This article was originally published in The Pink Sheet Daily

Executive Summary

Novartis plans to offer free drugs to low-income beneficiaries after they exhaust their $600 transitional assistance. The manufacturer is studying how to design an indigent population program for the full Medicare benefit.

You may also be interested in...



J&J Offers Free Drugs To Low-Income Medicare Discount Card Holders

Free drugs will be available to beneficiaries who exhaust the government’s $600 drug credit. J&J will also offer “competitive discounts” to seniors who do not qualify for the low-income program.

J&J Offers Free Drugs To Low-Income Medicare Discount Card Holders

Free drugs will be available to beneficiaries who exhaust the government’s $600 drug credit. J&J will also offer “competitive discounts” to seniors who do not qualify for the low-income program.

Medicare Drug Cards Would Provide 17% Discount On Average – Harvard Study

The percentage savings will be greater with generic drugs, but brand name pharmaceuticals will account for more absolute dollar savings, the study found.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059096

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel